Satellos Bioscience MSLE
NASDAQ MSLE
$8.55 -0.05 (-0.58%)
As of: Sep 30, 2026 · 3:58 PM EDT

Satellos Bioscience (MSLE) Net Income (2024 - 2026)

Updated

Satellos Bioscience (MSLE) posted Net Income of -$11.72 million for the quarter ended Jun 30, 2026, compared with -$17.89 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Net Income (2024 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Income at Satellos Bioscience was -$64.23 million; for the year ended Dec 31, 2025, it was -$24.87 million.

  • In prior years, Satellos Bioscience's Net Income was -$20.63 million in the year ended Dec 31, 2024.
  • Quarterly Net Income has run from a low of -$24.86 million in the quarter ended Dec 31, 2025 to a high of $6.14 million in the quarter ended Mar 31, 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 5.53 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.62 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -1.34 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 3.26 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 2.51 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 2.38 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -10.50 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -237.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.10 Bn
10 Satellos Bioscience 132.95 Mn 132.95 Mn - -11.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.72 Mn
Mar 31, 2026 -9.77 Mn
Dec 31, 2025 -24.86 Mn
Jun 30, 2025 -17.89 Mn
Mar 31, 2025 6.14 Mn
Dec 31, 2024 -22.73 Mn
API Access

Satellos Bioscience Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=MSLE&period=max&api_key=YOUR_API_KEY